Skip to content

Systematic treatment regiman of nodular sclerosis related renal angiomyolipoma based on surgical intervention

Systematic treatment regiman of nodular sclerosis related renal angiomyolipoma based on surgical intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095913
Enrollment
Unknown
Registered
2025-01-15
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberous Sclerosis Complex-Renal Angiomyolipoma

Interventions

MDT treatment group:Adopt an optimal comprehensive treatment strategy based on surgery, and at the same time, reduce the patients financial burden by reducing the amount of everolimus used, reducing t

Sponsors

West China hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age > 18 years old, with imaging measurable lesions in both kidneys or unilateral kidneys, > 3cm, and the number < five; The team assessed that surgery would resect large RAMLs with maximum preservation of normal nephrons; 2. No clear contraindications to surgery, such as severe cardiopulmonary insufficiency and coagulation dysfunction; 3. Patients are unwilling to take oral drugs for a long time, or cannot tolerate the side effects of drugs, or cannot tolerate the side effects of drug treatment.

Exclusion criteria

Exclusion criteria: 1. Age= 5; 4. The team assessed that it was difficult to resect large RAML with surgery, or that surgical resection could not preserve normal nephrons to the maximum, and the surgical benefit was limited; 5. Good drug treatment effect; 6. The patient has obvious contraindications to surgery, such as severe cardiopulmonary insufficiency and coagulation dysfunction.

Design outcomes

Primary

MeasureTime frame
Imaging efficacy assessment;Evaluation of clinical benefits;

Secondary

MeasureTime frame
Laboratory evaluation of renal function;

Countries

China

Contacts

Public ContactZhihong Liu

Department of Urology, West China hospital, Sichuan University

zhihong031@126.com+86 133 5087 9773

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026